快而精医药(QGEN)

49.285 -1.065 -2.1152%

今开:49.31昨收:50.35
最高:49.61 最低:49.15
涨停价:0.0跌停价:0.0
总市值:1.12221945E10

快而精医药的热门评论

美股滚雪球2021-11-04 11:25

有报道称$快而精医药(QGEN)$ 吸引了法国诊断公司bioMérieux的收购兴趣。
去年,$赛默飞世尔科技(TMO)$ 出价104亿欧元收购QGEN,但最终交易破裂,一周后Qigen董事长辞职,这次董事长还辞职吗?
$东方生物(SH688298)$查看全文

美股滚雪球2021-11-17 12:09

$赛默飞世尔科技(TMO)$ 据说又想并购$快而精医药(QGEN)$ 了,念念不忘,必有回响。$义翘神州(SZ301047)$查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

7X24快讯2021-07-12 23:14

市场消息:快而精医药(QGEN.N)将回购高达1亿美元股票。查看全文

JZee2021-06-21 09:41

$泛生子(GTH)$ 主页上有$快而精医药(QGEN)$ 合作字样。泛生子目前的检测服务和未来的肝癌早筛需给qiagen分成么?//@userfield:回复@张小丰:我倒是觉得这个行业现在不需要一口吃个胖子吧,应该是渐进式进步,先比临床日常用的检测方法有更好的灵敏度和特异性,然后采样方便,这样就有一定优势,可以...查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

快而精医药(QGEN)2021-05-05 18:42

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000031 Act: 34 Size: 1 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

快而精医药(QGEN)2021-03-05 19:12

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-21-000018 Act: 34 Size: 22 MB 网页链接查看全文

快而精医药(QGEN)2021-03-05 19:06

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-21-000020 Act: 34 Size: 32 KB 网页链接查看全文

快而精医药(QGEN)2021-02-25 05:21

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000010 Act: 34 Size: 49 KB 网页链接查看全文

快而精医药(QGEN)2021-02-12 04:27

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000912938-21-000178 Act: 34 Size: 17 KB 网页链接查看全文

快而精医药(QGEN)2021-02-10 19:27

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000007 Act: 34 Size: 487 KB 网页链接查看全文

快而精医药(QGEN)2021-02-04 02:27

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-21-000049 Act: 34 Size: 33 KB 网页链接查看全文

牛唐2021-02-01 13:42

$快而精医药(QGEN)$ 推出了在废水中检测新冠病毒的设备,为的是让政府采集更多的数据,尤其是那些没有保险覆盖的人群。$鲁抗医药(SH600789)$ $康希诺-U(SH688185)$查看全文

快而精医药(QGEN)2021-01-27 03:28

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-21-001206 Act: 34 Size: 13 KB 网页链接查看全文

快而精医药(QGEN)2021-01-09 05:51

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000004 Act: 34 Size: 50 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30